Shandong Pharmaceutical Glass Co (SHSE:600529) Cyclically Adjusted FCF per Share: ¥0.23 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600529 Shandong Pharmaceutical Glass Co Ltd SHSE:600529
90 GF Score
Price ¥19.32
GF Value ¥24.53
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shandong Pharmaceutical Glass Co Cyclically Adjusted FCF per Share?

Shandong Pharmaceutical Glass Co SHSE:600529 +0.05% 90 Cyclically Adjusted FCF per Share is ¥0.23 as of Mar. 2026. GuruFocus rates SHSE:600529 with a GF Score™ of 90/100 and a GF Value™ of ¥24.53 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Shandong Pharmaceutical Glass Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥0.003. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.23 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shandong Pharmaceutical Glass Co's average Cyclically Adjusted FCF Growth Rate was -4.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 13.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Shandong Pharmaceutical Glass Co was 76.50% per year. The lowest was -10.90% per year. And the median was 4.40% per year.

As of today (2026-08-07), Shandong Pharmaceutical Glass Co's current stock price is ¥19.32. Shandong Pharmaceutical Glass Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.23. Shandong Pharmaceutical Glass Co's Cyclically Adjusted Price-to-FCF of today is 84.00.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Shandong Pharmaceutical Glass Co was 338.57. The lowest was 43.48. And the median was 103.42.


Shandong Pharmaceutical Glass Co  (SHSE:600529) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shandong Pharmaceutical Glass Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=19.32/0.23
=84.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Shandong Pharmaceutical Glass Co was 338.57. The lowest was 43.48. And the median was 103.42.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Shandong Pharmaceutical Glass Co Cyclically Adjusted FCF per Share Related Terms


Shandong Pharmaceutical Glass Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Shandong Pharmaceutical Glass Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Pharmaceutical Glass Co Cyclically Adjusted FCF per Share Chart

Shandong Pharmaceutical Glass Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.17 0.20 0.25 0.25

Shandong Pharmaceutical Glass Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.23 0.22 0.25 0.23

SHSE:600529 vs SW, PKG, IP: Cyclically Adjusted FCF per Share Comparison

For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Pharmaceutical Glass Co Cyclically Adjusted Price-to-FCF vs Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shandong Pharmaceutical Glass Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:600529
90GF Score
Shandong Pharmaceutical Glass Co Ltd SHSE:600529
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Pharmaceutical Glass Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shandong Pharmaceutical Glass Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.003/116.3033*116.3033
=0.003

Current CPI (Mar. 2026) = 116.3033.

Shandong Pharmaceutical Glass Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.116 101.400 0.133
201609 0.208 102.400 0.236
201612 0.115 102.600 0.130
201703 0.034 103.200 0.038
201706 0.099 103.100 0.112
201709 0.067 104.100 0.075
201712 0.215 104.500 0.239
201803 -0.064 105.300 -0.071
201806 0.178 104.900 0.197
201809 0.080 106.600 0.087
201812 0.000 106.500 0.000
201903 -0.053 107.700 -0.057
201906 -0.079 107.700 -0.085
201909 -0.013 109.800 -0.014
201912 0.157 111.200 0.164
202003 -0.155 112.300 -0.161
202006 0.157 110.400 0.165
202009 -0.172 111.700 -0.179
202012 0.221 111.500 0.231
202103 -0.607 112.662 -0.627
202106 0.222 111.769 0.231
202109 0.082 112.215 0.085
202112 0.210 113.108 0.216
202203 -0.477 114.335 -0.485
202206 -0.010 114.558 -0.010
202209 -0.195 115.339 -0.197
202212 -0.090 115.116 -0.091
202303 0.117 115.116 0.118
202306 -0.057 114.558 -0.058
202309 0.147 115.339 0.148
202312 0.361 114.781 0.366
202403 0.239 115.227 0.241
202406 0.221 114.781 0.224
202409 0.078 115.785 0.078
202412 0.241 114.893 0.244
202503 -0.027 115.116 -0.027
202506 0.125 114.907 0.127
202509 0.091 115.471 0.092
202512 0.331 115.832 0.332
202603 0.003 116.303 0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.23 mean?
Shandong Pharmaceutical Glass Co (SHSE:600529) has a Cyclically Adjusted FCF per Share of ¥0.23 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Shandong Pharmaceutical Glass Co and its competitors.
Is Shandong Pharmaceutical Glass Co's Cyclically Adjusted FCF per Share too high?
Shandong Pharmaceutical Glass Co's current Cyclically Adjusted FCF per Share is ¥0.23. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's Cyclically Adjusted FCF per Share compare to SW and PKG?
Shandong Pharmaceutical Glass Co's Cyclically Adjusted FCF per Share of ¥0.23 can be compared against companies in the Packaging & Containers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Packaging & Containers company?
A good Cyclically Adjusted FCF per Share depends on the Packaging & Containers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Shandong Pharmaceutical Glass Co and its competitors. Shandong Pharmaceutical Glass Co's current Cyclically Adjusted FCF per Share is ¥0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.53, compared to a current price of ¥19.32 — trading 21.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.23. Shandong Pharmaceutical Glass Co's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current Cyclically Adjusted FCF per Share is ¥0.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued. The current stock price of ¥19.32 is trading 21.2% below its estimated GF Value™ of ¥24.53. GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.

Key valuation signals for SHSE:600529:

  • Cyclically Adjusted FCF per Share: ¥0.23
  • GF Value™: ¥24.53 vs. price of ¥19.32 (21.2% below fair value)
  • GF Score™: 90/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Pharmaceutical Glass Co Business Description

Address Yaobo Road, Yiyuan County, Zibo, Shandong, CHN, 256100
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
90GF Score

Get the complete analysis for SHSE:600529

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥19.32
Price
¥24.53
GF Value